Compare Citius Pharmaceuticals Inc (CTXR) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs United States Natural Gas Fund — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while United States Natural Gas Fund trades at $10.28. Which is the better fit depends on your goals.
| CTXR | UNG | |
|---|---|---|
Market Cap | $20.01M | — |
Sector | Health | Commodities - Energy |
52-Week High | $1.82 | $16.90 |
52-Week Low | $0.48 | $9.63 |
Enterprise Value | $16.23M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
